Analysis of Cardiac Amyloidosis Progression Using Model-Based Markers

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Imaging

Background:

• Cardiac amyloidosis causes heart failure through myocardial stiffening and impaired pumping.
• Current understanding of cardiac amyloidosis progression and its predictors is limited.
• Biomarkers are needed to track clinical deterioration and guide treatment development.

Purpose of the Study:

• To identify key predictors for cardiac amyloidosis disease progression.
• To assess the potential of mathematical modeling of the left ventricle for predicting disease advancement.
• To evaluate the clinical utility of novel biomarkers derived from cardiac imaging.

Main Methods:

• Mathematical modeling of the left ventricle using routine clinical magnetic resonance imaging (MRI) and follow-up scans.
• Application of mechanical modeling and statistical classification techniques.
• Double-blind testing of predictions against clinical assessments.

Main Results:

• It is possible to predict disease progression in cardiac amyloidosis using the developed mathematical models.
• Predictions showed agreement with clinical assessments in 6 out of 7 cases.
• Reliable prediction requires integrating multiple factors, including mechanical, geometrical, and shape features, rather than relying on a single marker.

Conclusions:

• A multi-factorial approach combining mechanical, geometrical, and shape features from MRI is promising for predicting cardiac amyloidosis progression.
• This approach shows potential for clinical translation in managing heart failure due to cardiac amyloidosis.
• Further validation with larger sample sizes is necessary due to the proof-of-concept nature and small cohort.